- Home
- MKTW vs DXR Comparison
MKTW vs DXR Comparison
Compare MKTW & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MKTW | DXR |
|---|---|---|
| Founded | 1999 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 54.6M | 59.0M |
| IPO Year | 2020 | 1995 |
Fundamental Metrics
Financial Performance| Metric | MKTW | DXR |
|---|---|---|
| Price | $18.40 | $11.75 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $20.00 | N/A |
| AVG Volume (30 Days) | 16.8K | ★ 17.4K |
| Earning Date | 05-07-2026 | 02-27-2026 |
| Dividend Yield | ★ 10.20% | N/A |
| EPS Growth | ★ 1183.33 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $512,403,000.00 | $1,446,345.00 |
| Revenue This Year | $1.52 | $44,935.22 |
| Revenue Next Year | $4.55 | $74.79 |
| P/E Ratio | ★ N/A | $33.83 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.49 | $8.56 |
| 52 Week High | $22.83 | $14.76 |
Technical Indicators
Market Signals| Indicator | MKTW | DXR |
|---|---|---|
| Relative Strength Index (RSI) | 43.86 | 60.05 |
| Support Level | $16.22 | $9.26 |
| Resistance Level | $18.84 | $12.08 |
| Average True Range (ATR) | 0.50 | 0.74 |
| MACD | 0.04 | 0.13 |
| Stochastic Oscillator | 34.11 | 68.02 |
Price Performance
Historical ComparisonAbout MKTW MarketWise Inc.
Marketwise Inc is a multi-brand subscription services platform providing premium financial research, software, education, and tools for investors. Its products are built for high-value financial research, education, actionable investment ideas, and investment software. It is a digital, direct-to-consumer company offering its research across a variety of platforms, including mobile, desktop, and tablets.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system.